Evidence map›Paper›PMID 39023083›Full record

ArticleProtein science : a publication of the Protein Society2024

A suicidal and extensively disordered luciferase with a bright luminescence.

Fenne Marjolein Dijkema, Marta Iglesia Escarpizo-Lorenzana, Matilde Knapkøien Nordentoft, Hanna Christin Rabe, Cagla Sahin, Michael Landreh, Rui Mamede Branca, Esben Skipper Sørensen, Brian Christensen, Andreas Prestel and 2 more

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Tumor-targeting bioluminescent bacteria forEngineering microbiology · 2025
    Article
  4. Article
  5. Article
  6. A suicidal and extensively disordered luciferase with a bright luminescence.Protein science : a publication of the Protein Society · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Fenne Marjolein DijkemaThe Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
Marta Iglesia Escarpizo-LorenzanaThe Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
Matilde Knapkøien NordentoftThe Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
Hanna Christin RabeThe Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
Cagla SahinThe Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
Michael LandrehDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-7958-4074
Rui Mamede BrancaScience for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Esben Skipper SørensenDepartment of Molecular Biology and Genetics, Section for Cellular Health, Intervention and Nutrition, Aarhus University, Aarhus Centrum, Denmark.
Brian ChristensenDepartment of Molecular Biology and Genetics, Section for Cellular Health, Intervention and Nutrition, Aarhus University, Aarhus Centrum, Denmark.
Andreas PrestelThe Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
Kaare TeilumThe Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0001-6919-1982
Jakob Rahr WintherThe Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0001-6995-9154

Funding

Novo Nordisk Foundation NNF18OC0032996Novo Nordisk Foundation NNF19OC0058579
6 · The paper itself

Abstract

Gaussia luciferase (GLuc) is one of the most luminescent luciferases known and is widely used as a reporter in biochemistry and cell biology. During catalysis, GLuc undergoes inactivation by irreversible covalent modification. The mechanism by which GLuc generates luminescence and how it becomes inactivated are however not known. Here, we show that GLuc unlike other enzymes has an extensively disordered structure with a minimal hydrophobic core and no apparent binding pocket for the main substrate, coelenterazine. From an alanine scan, we identified two Arg residues required for light production. These residues separated with an average of about 22 Å and a major structural rearrangement is required if they are to interact with the substrate simultaneously. We furthermore show that in addition to coelenterazine, GLuc also can oxidize furimazine, however, in this case without production of light. Both substrates result in the formation of adducts with the enzyme, which eventually leads to enzyme inactivation. Our results demonstrate that a rigid protein structure and substrate-binding site are no prerequisites for high enzymatic activity and specificity. In addition to the increased understanding of enzymes in general, the findings will facilitate future improvement of GLuc as a reporter luciferase.

Indexed as

LuciferasesAnimalsCopepodaImidazolesIntrinsically Disordered ProteinsLuminescenceModels, MolecularPyrazinescoelenterazineImidazolesIntrinsically Disordered ProteinsLuciferasesPyrazinesactive siteenzymeintrinsic disorderluciferaseNMRoxidationstructure

Identifiers

PMID39023083
PMCPMC11255867

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.